Continuous worsening of population emotional stress globally: universality and variations.

Publication date: Dec 23, 2024

Understanding emotional stress stability in populations is crucial because stress is a key factor in causing depression, and it worsens well-being. In this study, using repeated cross-sectional data from 149 countries from 2007 to 2021 (N = 2,450,043), we examined time trends of psychological stress in populations worldwide. Over half of the population experienced emotional stress in 20 countries, and 85% of the countries reported worse psychological stress in 2020 compared with 2008. We found that psychological well-being declined most rapidly among young people compared with other age groups. Individuals living and working in all types of locations (rural/farm, town/village, large city, and suburban areas) and employment (full-time, self-employed, part-time, and unemployed), respectively, experienced continuously worsening emotional stress when comparing three time periods (2008-2011, 2012-2019, and 2020-2021). Furthermore, reducing physical pain and increasing income were noted to be more important than solving health problems for the purpose of decreasing stress. Emotional stress continuously worsened worldwide over the past few decades, but the trend varied among countries. Our findings highlight the significance of improving people’s living environments to reduce their likelihood of experiencing emotional stress.

Open Access PDF

Concepts Keywords
Rural COVID-19
Worsening Emotional stress
Multination
Psychological well-being

Semantics

Type Source Name
disease MESH emotional stress
disease MESH depression
disease MESH psychological well-being
pathway REACTOME Reproduction
disease MESH COVID 19
disease MESH anxiety
disease MESH cardiovascular diseases
disease MESH cancers
drug DRUGBANK Coenzyme M
disease MESH mental illness
disease MESH backaches
disease MESH sore throat
disease MESH occupational stress
drug DRUGBANK Serine
disease MESH burnout
disease IDO country
drug DRUGBANK Aspartame
drug DRUGBANK Polyethylene glycol
disease MESH educational attainment
disease MESH shock
disease MESH psychological distress
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Tretamine
drug DRUGBANK Isosorbide Mononitrate
disease MESH psychosis
disease MESH mild cognitive impairment
disease MESH morbidity

Original Article

(Visited 1 times, 1 visits today)